N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide

C48H48N14O6S5 — CID 123790746

IUPACN-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide
SMILESO=C(Cc1ccccc1)Nc1nnc(CCCCCCc2nnc(NC(=O)Cc3cccc(-c4ccnc(CC(=O)Nc5nnc(CCS(=O)(=O)CCc6nnc(NC(=O)Cc7ccccn7)s6)s5)c4)c3)s2)s1
InChIInChI=1S/C48H48N14O6S5/c63-37(26-31-11-4-3-5-12-31)51-45-59-55-41(69-45)16-6-1-2-7-17-42-56-60-46(70-42)52-38(64)27-32-13-10-14-33(25-32)34-18-22-50-36(28-34)30-40(66)54-48-62-58-44(72-48)20-24-73(67,68)23-19-43-57-61-47(71-43)53-39(65)29-35-15-8-9-21-49-35/h3-5,8-15,18,21-22,25,28H,1-2,6-7,16-17,19-20,23-24,26-27,29-30H2,(H,51,59,63)(H,52,60,64)(H,53,61,65)(H,54,62,66)
InChIKeyVGNBFRSJYAMJAM-UHFFFAOYSA-N
MW1077.34 g/mol
LogP6.82
Rot. Bonds26

About N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide

N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide (PubChem CID 123790746) has the molecular formula C48H48N14O6S5 and a molecular weight of 1077.34 g/mol. Its IUPAC name is N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide.

Molecular Properties

Compound NameN-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide
PubChem CID123790746
Molecular FormulaC48H48N14O6S5
Molecular Weight1077.34 g/mol
Exact Mass1076.25
IUPAC NameN-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide
SMILESO=C(Cc1ccccc1)Nc1nnc(CCCCCCc2nnc(NC(=O)Cc3cccc(-c4ccnc(CC(=O)Nc5nnc(CCS(=O)(=O)CCc6nnc(NC(=O)Cc7ccccn7)s6)s5)c4)c3)s2)s1
InChIInChI=1S/C48H48N14O6S5/c63-37(26-31-11-4-3-5-12-31)51-45-59-55-41(69-45)16-6-1-2-7-17-42-56-60-46(70-42)52-38(64)27-32-13-10-14-33(25-32)34-18-22-50-36(28-34)30-40(66)54-48-62-58-44(72-48)20-24-73(67,68)23-19-43-57-61-47(71-43)53-39(65)29-35-15-8-9-21-49-35/h3-5,8-15,18,21-22,25,28H,1-2,6-7,16-17,19-20,23-24,26-27,29-30H2,(H,51,59,63)(H,52,60,64)(H,53,61,65)(H,54,62,66)
InChIKeyVGNBFRSJYAMJAM-UHFFFAOYSA-N
XLogP6.82
TPSA279.44 Ų
H-Bond Donors4
H-Bond Acceptors20
Rotatable Bonds26
Heavy Atoms73
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5001077.34
LogP ≤ 56.82
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1020

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Aliphatic_long_chain', 'substructure': 'N/A'}

Analyze N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide?
The IUPAC name of N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide (CID 123790746) is N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide.
What is the SMILES notation for N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide?
The canonical SMILES for N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide is O=C(Cc1ccccc1)Nc1nnc(CCCCCCc2nnc(NC(=O)Cc3cccc(-c4ccnc(CC(=O)Nc5nnc(CCS(=O)(=O)CCc6nnc(NC(=O)Cc7ccccn7)s6)s5)c4)c3)s2)s1.
What is the InChIKey of N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide?
The InChIKey is VGNBFRSJYAMJAM-UHFFFAOYSA-N. The full InChI is InChI=1S/C48H48N14O6S5/c63-37(26-31-11-4-3-5-12-31)51-45-59-55-41(69-45)16-6-1-2-7-17-42-56-60-46(70-42)52-38(64)27-32-13-10-14-33(25-32)34-18-22-50-36(28-34)30-40(66)54-48-62-58-44(72-48)20-24-73(67,68)23-19-43-57-61-47(71-43)53-39(65)29-35-15-8-9-21-49-35/h3-5,8-15,18,21-22,25,28H,1-2,6-7,16-17,19-20,23-24,26-27,29-30H2,(H,51,59,63)(H,52,60,64)(H,53,61,65)(H,54,62,66).
What are the key properties of N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide?
N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide has a molecular weight of 1077.34 g/mol, XLogP of 6.82, 26 rotatable bonds, 4 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[5-[6-[5-[[2-[3-[2-[2-oxo-2-[[5-[2-[2-[5-[(2-pyridin-2-ylacetyl)amino]-1,3,4-thiadiazol-2-yl]ethylsulfonyl]ethyl]-1,3,4-thiadiazol-2-yl]amino]ethyl]-4-pyridinyl]phenyl]acetyl]amino]-1,3,4-thiadiazol-2-yl]hexyl]-1,3,4-thiadiazol-2-yl]-2-phenylacetamide is sourced from PubChem (CID 123790746), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).